Archive for the ‘Word Press’ Category

Careful hitting Giants with sports’ worst 4-letter word: Quit

Heres a lesson I learned the hard way:

This was the Monday after Thanksgiving, two seasons ago, high above the Superdome, inside a press box virtually scraping the ceiling. The Giants were playing a prime-time game against the Saints and they were getting hammered. Actually, it was worse than that. They were getting manhandled, humiliated, emasculated.

Even from up there, it seemed like a senseless battering, one that would end 49-24 and one that, at some point, felt like the Giants wouldve preferred to be anywhere else in the world but New Orleans. And so for the pending edition of the paper, I wrote that, using the worst four-letter word in sports: Q-U-I-T.

Then, at games end, we hurried downstairs, walked into the locker room, and this was what we saw: a room packed with bloodied, battered players, all of them limping, all of them dragging themselves to the showers and the trainers room, all of them looking the best word is this: vanquished.

Justin Tuck was one of them. And something he said stayed with me, and stays with me:

Theres a big difference, Tuck said, between quitting and getting your head handed to you.

I quickly rewrote my column, hastening to delete with urgency a certain word entirely from the final edition. And its a point worth pondering this morning, as we try to think about where the Giants are as a team right now. Yes, they got good and pounded by the Panthers on Sunday. A lot of Giants fans turned the game off. Those that were forced to stay saw something that fell between grisly and gruesome.

Carl Banks, for one, as a Giants broadcaster, had to watch every snap. And his mood rapidly darkened as the game got further and further out of hand. And it hadnt gotten any better by the time he talked with WFANs Evan Roberts and Joe Benigno on Monday. Banks never used the Q word, but he used a lot of its cousins, calling the Giants emotion-free, wondering whether the players liked each other, questioning their self-respect.

Later, one of Banks teammates from their shared golden era, Harry Carson, told ESPN: Thats not being a Giant. Theres a certain amount of pride and dignity when you put on that uniform and take the field.

Old Giants do tend to take the red-white-and-blue team colors seriously, transform them into sacred vestments the further removed they are from the field, and theres nothing wrong with that: There ought to be pride in a career well played, a football life well-lived.

Originally posted here:
Careful hitting Giants with sports’ worst 4-letter word: Quit

Word Press Blogging Tutorial – Video


Word Press Blogging Tutorial
A tutorial video on how to create blog posts on our http://www.RainbowPsychics.com Word Press website...

By: RainbowPsychics

See the article here:
Word Press Blogging Tutorial - Video

Installing Word Press on a New Website – Video


Installing Word Press on a New Website

By: Troy R James

Original post:
Installing Word Press on a New Website - Video

DGAP-News: MOLOGEN AG submitted clinical trial application (IND) for MGN1703 to the FDA

---------------------------------------------------------------------

PRESS RELEASE N 8 / 2013 of 09/24/2013

MOLOGEN AG submitted clinical trial application (IND) for MGN1703 to the FDA

* Investigational New Drug (IND) application for the treatment of solid tumors * Phase I clinical study in the U.S. to determine cardiac safety of MGN1703

Berlin, September 24, 2013 - MOLOGEN AG filed an Investigational New Drug (IND) application for MGN1703 with the U.S. Food and Drug Administration (FDA) to initiate a phase I clinical trial. The placebo-controlled, double-blind study is designed to determine the cardiac safety of MGN1703 and to evaluate pharmacokinetic parameters in healthy volunteers. The trial is expected to start as soon as the FDA has granted its approval.

Alfredo Zurlo, M.D., Chief Medical Officer of MOLOGEN AG stated, 'With the IND application we are preparing the ground to develop our lead drug candidate MGN1703 for the treatment of solid tumors also in the USA. After the very promising final results of the IMPACT trial presented earlier this year we are now very much looking forward to proceeding with our clinical development program for MGN1703.'

MGN1703 has already successfully completed a phase II study in metastatic colorectal cancer (mCRC) in Europe. MOLOGEN is currently also preparing a pivotal study in mCRC and a phase II study in lung cancer for MGN1703. In parallel licensing activities for MGN1703 are ongoing.

About IMPACT study with MGN1703

The IMPACT study was a phase II, randomized, placebo-controlled, double-blind, multicenter clinical study to determine the efficacy of MGN1703 as maintenance therapy following first-line chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer.

Patients included in the IMPACT study had stabilization, or partial or complete remission of their disease after receiving first-line therapy for 4.5 to 6 months. During the study, patients were randomized to receive either MGN1703 or placebo twice per week. The treatment was continued until tumor progression was detected. Overall 59 patients were enrolled in the study. Patients' characteristics were globally balanced between treatment groups.

Continue reading here:
DGAP-News: MOLOGEN AG submitted clinical trial application (IND) for MGN1703 to the FDA

Room Cartoons Word Press + Download – Video


Room Cartoons Word Press + Download
Download here: http://goo.gl/aslEAZ Room Cartoons is an full responsive, very beautiful and clean Word Press theme, that is perfect for freelancers, photogra...

By: newthemeupdate

Read this article:
Room Cartoons Word Press + Download - Video